April 2, 2022, is World Autism Awareness Day. At the HER Foundation, we light up kindness and wear blue in support of understanding and acceptance for people with autism. Children born after an HG pregnancy have an increased risk of an autism diagnosis, and we are grateful for each of these children.
Join us November 6-7, 2024 in Ventura, California (near LA), for two days of engaging with top scientists and clinicians specializing in HG management.
Dr. Marlena Fejzo, geneticist and HER’s Research Advisor and member of the Board of Directors, was featured in the Inverse article, “When morning sickness kills: doctors have dismissed hyperemesis gravidarum for decades, but new research could undo this harmful legacy.”
21 Years of Hyperemesis Gravidarum (HG) Impact was made possible by the support of our amazing community. And there is such hope for change. Don’t you feel it! Here at HER, we are ready for a BIG day in the nonprofit world: Giving Tuesday, November 30, 2021. Giving Tuesday (GT) is the largest giving day of the year, and we want to make this year’s GT our best yet!
HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
The Hyperemesis Education and Research Foundation’s mission is to provide Hyperemesis Gravidarum (HG) support, advocacy, education, and research to improve treatment and outcomes.
The HER Foundation publishes a new study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of NVP.
Support another 20 years of helping mothers and babies thrive. HER is the global voice and leader for HG research and education.
Stella Inger Escobedo reports on hyperemesis gravidarum (HG) and the HER Foundation on The CW San Diego. The piece features Escobedo’s diagnosis with HG in first trimester and interviews with…

